BioMarin Pharma cites positive results for hemophilia treatment
January 08, 2017 at 21:19 PM EST
Jan 8 (Reuters) - BioMarin Pharmaceutical Inc announced on Sunday what it called "positive interim results" from its study of a gene therapy treatment for severe hemophilia.
